Search by Drug Name or NDC
NDC 00591-2579-20 Valganciclovir hydrochloride for Oral 50 mg/mL Details
Valganciclovir hydrochloride for Oral 50 mg/mL
Valganciclovir hydrochloride for Oral is a ORAL POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is VALGANCICLOVIR HYDROCHLORIDE.
MedlinePlus Drug Summary
Valganciclovir is used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people who have acquired immunodeficiency syndrome (AIDS). Valganciclovir is also used to prevent cytomegalovirus (CMV) disease in people who have received a heart, kidney, or kidney-pancreas transplant and who have a chance of getting CMV disease. Valganciclovir is in a class of medications called antivirals. It works by preventing the spread of CMV disease or slowing the growth of CMV.
Related Packages: 00591-2579-20Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Valganciclovir
Product Information
| NDC | 00591-2579 |
|---|---|
| Product ID | 0591-2579_9f669f81-9b46-440d-bb4f-0696098da2cc |
| Associated GPIs | 12200066102120 |
| GCN Sequence Number | 064506 |
| GCN Sequence Number Description | valganciclovir HCl SOLN RECON 50 MG/ML ORAL |
| HIC3 | W5A |
| HIC3 Description | ANTIVIRALS, GENERAL |
| GCN | 14453 |
| HICL Sequence Number | 022033 |
| HICL Sequence Number Description | VALGANCICLOVIR HCL |
| Brand/Generic | Generic |
| Proprietary Name | Valganciclovir hydrochloride for Oral |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Valganciclovir hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205220 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00591-2579-20 (00591257920)
| NDC Package Code | 0591-2579-20 |
|---|---|
| Billing NDC | 00591257920 |
| Package | 100 mL in 1 BOTTLE, GLASS (0591-2579-20) |
| Marketing Start Date | 2016-08-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 4.92836 |
| Pricing Unit | ML |
| Effective Date | 2022-09-21 |
| NDC Description | VALGANCICLOVIR HCL 50 MG/ML |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis